SE409323B - Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer - Google Patents

Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer

Info

Publication number
SE409323B
SE409323B SE7203303A SE330372A SE409323B SE 409323 B SE409323 B SE 409323B SE 7203303 A SE7203303 A SE 7203303A SE 330372 A SE330372 A SE 330372A SE 409323 B SE409323 B SE 409323B
Authority
SE
Sweden
Prior art keywords
afthyl
tetrahydrone
isomers
trans
phosphoric acid
Prior art date
Application number
SE7203303A
Other languages
English (en)
Swedish (sv)
Inventor
R Viterbo
J Jacques
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE409323B publication Critical patent/SE409323B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Braiding, Manufacturing Of Bobbin-Net Or Lace, And Manufacturing Of Nets By Knotting (AREA)
SE7203303A 1971-03-18 1972-03-15 Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer SE409323B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49167/71A IT951631B (it) 1971-03-18 1971-03-18 Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi

Publications (1)

Publication Number Publication Date
SE409323B true SE409323B (sv) 1979-08-13

Family

ID=11269830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7203303A SE409323B (sv) 1971-03-18 1972-03-15 Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer

Country Status (18)

Country Link
US (1) US3848030A (en:Method)
JP (1) JPS5547013B1 (en:Method)
AU (1) AU462431B2 (en:Method)
BE (1) BE780887A (en:Method)
CA (1) CA961500A (en:Method)
CH (1) CH576921A5 (en:Method)
DE (1) DE2212660C3 (en:Method)
DK (1) DK139944B (en:Method)
ES (1) ES400862A1 (en:Method)
FR (1) FR2129741A5 (en:Method)
GB (1) GB1360946A (en:Method)
IL (1) IL38860A (en:Method)
IT (1) IT951631B (en:Method)
NL (1) NL7203574A (en:Method)
NO (1) NO136357C (en:Method)
PH (1) PH10768A (en:Method)
SE (1) SE409323B (en:Method)
ZA (1) ZA721297B (en:Method)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143028A (en) * 1977-12-05 1979-03-06 Ciba-Geigy Corporation Alkylated 1,1'-biphenyl-2,2'-diyl phosphonites and stabilized compositions
US5288914A (en) * 1984-08-27 1994-02-22 The Dow Chemical Company Poly(arylcyclobutenes)
NL8403224A (nl) * 1984-10-24 1986-05-16 Oce Andeno Bv Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
DE3940765A1 (de) * 1989-12-09 1991-06-13 Hoechst Ag Verfahren zur herstellung reiner cyclischer phosphorsaeurediarylester
DE69517810T2 (de) * 1994-05-16 2000-12-14 Merrell Pharmaceuticals Inc., Cincinnati Verfahren und diastereomere salze nützlich bei der racemattrennung von racemischer 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylphenyl essigsäure sowie entsprechende diastereomere salze
US6274745B1 (en) 1999-03-24 2001-08-14 Tosoh Corporation Binaphthol monophosphoric acid derivative and its use
JP4725757B2 (ja) * 1999-03-24 2011-07-13 東ソー株式会社 ビナフトールリン酸誘導体及びその利用
EP1227085B1 (en) 1999-10-22 2006-03-15 Takeda Pharmaceutical Company Limited Process for producing optically active naphthalene derivative and optical resolver therefor
EP1229019A4 (en) * 1999-11-10 2004-08-18 Takeda Chemical Industries Ltd METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE, CYCLIC ENAMINONE DERIVATIVES
US6391926B2 (en) * 2000-03-13 2002-05-21 Tosoh Corporation Optically active phosphate derivative
PT1411916E (pt) 2001-07-09 2008-12-10 Repros Therapeutics Inc Métodos e materiais para o tratamento de deficiência em testosterona nos homens
US7517828B2 (en) * 2003-04-25 2009-04-14 Toagosei Co., Ltd. Chiral broensted acid catalyst for asymmetric synthesis and method of asymmetric synthesis with the catalyst
US7229557B2 (en) * 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
EP2486032A4 (en) * 2009-10-09 2013-03-27 Hetero Research Foundation RACEMATSPALTUNG SUBSTITUTED 2- (2-PYRIDINYLMETHYLSULFINYL) -1H-BENZIMIDAZOLE
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
US20150202167A1 (en) 2012-08-21 2015-07-23 Repros Therapeutics Inc. Trans-Clomiphene Formulations and Uses Thereof
CA2889770A1 (en) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Trans-clomiphene for use in cancer therapy
WO2015138340A1 (en) * 2014-03-11 2015-09-17 Repros Therapeutics Inc. Clomiphene synthesis using a single solvent
CN107072969B (zh) 2014-07-24 2020-04-21 艾森潘帕克制药股份有限公司 使用顺式氯米芬治疗雄激素剥夺疗法诱导的热潮红和骨丢失
EP3015454A1 (en) 2014-10-28 2016-05-04 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Stable solid form of trans-Clomiphene citrate
EP3015453B1 (en) 2014-10-28 2016-10-12 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of Clomiphene
CA2989364C (en) 2016-04-22 2021-07-20 F.I.S. - Fabbrica Italiana Sintetici S.P.A. Process for the preparation of enclomiphene citrate having needle shaped crystal habit.
AU2018329202B2 (en) 2017-09-11 2022-10-27 Atossa Therapeutics, Inc. Methods for making and using endoxifen
FR3082842A1 (fr) * 2018-06-21 2019-12-27 Veru Inc. Polymorphe de cis-clomiphene (zuclomiphene) et procedes d'utilisation de celui-ci
US12201591B2 (en) 2019-07-03 2025-01-21 Atossa Therapeutics, Inc. Sustained release compositions of endoxifen
CA3098725A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Zuclpomiphene salts and crystalline forms thereof
CA3098552A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Processes for the preparation of zuclomiphene and intermediates thereof
CA3105944A1 (en) 2020-01-22 2021-07-22 Apotex Inc. Crystalline forms of zuclomiphene citrate
EP3907213A1 (en) 2020-05-04 2021-11-10 Pcas Processes for the production of isomerically pure or enriched cis-clomiphene
US11578025B2 (en) 2020-10-19 2023-02-14 Apotex Inc. Processes for the preparation of zuclomiphene intermediates

Also Published As

Publication number Publication date
ES400862A1 (es) 1976-04-16
IT951631B (it) 1973-07-10
ZA721297B (en) 1973-03-28
DE2212660B2 (de) 1980-07-10
DK139944B (da) 1979-05-21
CA961500A (en) 1975-01-21
US3848030A (en) 1974-11-12
DE2212660A1 (de) 1972-09-28
FR2129741A5 (en:Method) 1972-10-27
IL38860A0 (en) 1972-04-27
AU462431B2 (en) 1975-06-09
NO136357C (no) 1977-08-24
NL7203574A (en:Method) 1972-09-20
DE2212660C3 (de) 1981-09-24
PH10768A (en) 1977-09-05
IL38860A (en) 1975-06-25
BE780887A (fr) 1972-07-17
AU3961172A (en) 1973-09-06
DK139944C (en:Method) 1979-10-22
JPS5547013B1 (en:Method) 1980-11-27
GB1360946A (en) 1974-07-24
NO136357B (en:Method) 1977-05-16
CH576921A5 (en:Method) 1976-06-30

Similar Documents

Publication Publication Date Title
SE409323B (sv) Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer
SU698518A3 (ru) Устройство дл насыщени крови кислородом
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE400296B (sv) Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra
SE7803860L (sv) Forfarande for framstellning av 7-d-(-)-alfa-amino-alfa(p-hydroxifenylacetamido)desacetoxicefalosporansyra
NO138615C (no) Anvendelse av et amin for fremstilling av vandige, stabile opploesninger av 1,2-benzisotiazolon
SE7700442L (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
NO147917C (no) Fremgangsmaate for fremstilling av 3-metyl-delta3-cefem-4-karboksylsyre-forbindelser
SE416302B (sv) Forfarande for framstellning av foreningar tillhorande dihydrolysergsyra- och dihydroisolysergsyraserien
SE397973B (sv) Forfarande for framstellning av bensoylfenylsmorsyraderivat
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
NO144170C (no) Fremgangsmaate til fremstilling av desacetoksy-cefalosporansyrederivater.
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
NO763231L (no) Fremgangsm}te til fremstilling av 6beta,17-dihydroksy-7alfa-(lavere alkoksy)karbonyl-3-okso-17alfa-pregn-4-en-21-karboksylsyre gamma-laktoner.
NO140135C (no) Fremgangsmaate for fremstilling av d(-)-penicillamin og salter av dette
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE396599B (sv) Forfarande for framstellning av 1,2-di-substituerade hydraziner
SE380263B (sv) Forfarande for framstellning av 10-oxo-7,10-dihydro-1h-dioxino-(5,4-f)-9-kinolyl-karbonsyror
SE392724B (sv) Forfarande for framstellning av 7-aminocefalosporansyra
NO138635C (no) Hjoerneforbindelse, samt fremgangsmaate for fremstilling av slik